Muhammad Ali

Oslo University Hospital — Norway

Medicine · Health Sciences

10h-index739citations13works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(4), Liver Disease Diagnosis and Treatment(3), Hepatitis C virus research(2), Liver Disease and Transplantation(2), Hepatitis B Virus Studies(2)

Publications13 total

A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
Nature Cancer·2023· 34 citedOpen Access
PB2501: INSIGHT-1: A PHASE I FIRST-IN-HUMAN TCR TRIAL OF GENETICALLY MODIFIED T-CELLS TARGETING TDT IN CHILDREN AND ADULTS WITH T- AND B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (TRIAL-IN-PROGRESS)
HemaSphere·2023Open Access
Myeloperoxidase exerts anti-tumor activity in glioma after radiotherapy
Neoplasia·2022· 10 citedOpen Access
Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion
Nature Nanotechnology·2021· 103 citedOpen Access
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
Nature Biotechnology·2021· 34 citedOpen Access
Induction of neoantigen-reactive T cells from healthy donors
Nature Protocols·2019· 105 citedOpen Access
Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy
npj Breast Cancer·2019· 136 citedOpen Access
Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models
Cancer Immunology Immunotherapy·2016· 12 citedOpen Access
Myeloperoxidase–Hepatocyte–Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis
Antioxidants and Redox Signaling·2015· 134 citedOpen Access
Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis
The Journal of Experimental Medicine·2014· 150 citedOpen Access
Weight loss in HCV patients can be used as a surrogate marker for evaluation of interferon (IFN-α) treatment efficacy - a prospective pilot study.
PubMed·2014· 2 cited
376 Cirrhosis Predicts Mortality in Hospitalized Patient Requiring Dialysis for Acute Kidney Injury (AKI) and Is an Independent Risk Factor for New Hemodialysis
Gastroenterology·2013
FREQUENCY OF HCV INFECTION AND ITS GENOTYPES AMONG PATIENTS ATTENDING A LIVER CLINIC AND VOLUNTARY BLOOD DONORS IN A RURAL AREA OF PAKISTAN
Pakistan Journal of Medical Sciences·2009· 19 citedOpen Access

Frequent Co-authors

John W. Chen(4), Eirini Giannakopoulou(4), Johanna Olweus(4), Benjamin Pulli(3), Jenny Linnoila(3), Weiwen Yang(3), Yoshiko Iwamoto(2), Theodossis A. Theodossiou(2), Mantas Grigalavicius(2), Matthias Zeller(2), Zsófia Földvári(2), Erlend Strønen(2), Mireille Toebes(2), Ton N. Schumacher(2), Madeleine Lehander(2), Stina Virding Culleton(2), Yingqian Li(2), Even H Rustad(2), Ravi Chand Bollineni(2), Thea Johanne Gjerdingen(2)